Nd:YAG vs Alexandrite Laser Treatment in Hidradenitis Suppurativa

Starting soon · Not applicable

Conditions studied: Hidradenitis Suppurativa (HS)

In brief

The purpose of this study is to evaluate whether Alexandrite laser treatment is non-inferior to Nd:YAG (neodymium-doped yttrium aluminum garnet) laser treatment of hidradenitis suppurativa (HS).

Key facts

Study ID

NCT06960447

Run by

Geisinger Clinic

People needed

21

Starts

2026-07-01

Expected to finish

2027-07-01

Last updated by the study team

2026-04-28

Who can join

Age: 12 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Geisinger male or female patients with a diagnosis of hidradenitis suppurativa (all stages of disease)
• 12-75 years of age
• Not on concurrent systemic therapy (e.g., antibiotics, biologic therapies)
• Must have not used systemic therapies within 2 weeks of enrollment in study
• Able and willing to provide consent

You may not qualify if…

• Patients who cannot tolerate laser therapy
• Patients who cannot wear protective eyewear
• Patients who are pregnant

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.